TECX
Tectonic Therapeutic, Inc.
Next earnings Aug 5, 2026 · consensus $-1.38 EPS
Last earnings -7.4% on 2026-05-07
$31.99
▲ +3.09%$31.99▲ +70.61%
over 1Y
L $14.71EODHDH $35.87
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.1%
1W+5.4%
1M+5.1%
3M+9.0%
YTD+53.0%
1Y+70.6%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 16 analysts
Strong Buy
Conservative balance sheet (liabilities/equity 0.04x).
Return on equity -29.5% · latest
Tectonic Therapeutic, Inc. shows limited reported revenue, and -29.5% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$119M | -$105M | -$44.6M | -$58.0M | -$84.0M |
| Net income | -$119M | -$106M | -$42.8M | -$58.0M | -$74.2M |
| Diluted EPS | -$2.78 | -$2.42 | -$33.76 | -$6.83 | -$4.05 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$362M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-12.3%
FCF yield-10.0%
Quality & risk
ROIC (est.)-24.9%
Free cash flow-$60.3M
Total debt$15.0M
Net cash$239M
Piotroski F-Score4/7
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.6%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-202026-06-23open ↗4Period ending 2026-06-112026-06-12open ↗8-KPeriod ending 2026-06-082026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗3Period ending 2026-06-082026-06-10open ↗8-KPeriod ending 2026-05-072026-05-07open ↗10-QPeriod ending 2026-03-312026-05-07open ↗4Period ending 2026-05-042026-05-06open ↗
Frequently asked
- Is Tectonic Therapeutic, Inc. (TECX) a buy?
- TECX currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.04x).
- What is Tectonic Therapeutic, Inc.'s quality score?
- TECX scores 36.179487179487175/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001681087, latest 10-Q filed 2026-05-07) · EODHD · as of 6/26/2026, 8:11:12 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.